A Case of Non-Compacted Left Ventricle and Lung Squamous Cell Carcinoma With Multiple Left Ventricular Clots

Document Type : Case Report

Authors

1 Cardio-Oncology Department and Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, IR Iran.

2 Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, IR Iran.

3 Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, IR Iran.

Abstract

Left ventricular (LV) non-compaction is a genetic disease which might result in heart failure, arrhythmias, and thromboembolic events. Nonetheless, other diseases and drugs or toxins like chemotherapy agents can also simulate or exacerbate this phenotype and accelerate systolic dysfunction. Moreover, cancer and receiving chemotherapy agents are procoagulant states leading to venous, arterial, and intracardiac thromboses.
Case: A 62-year-old man with a history of lung squamous cell carcinoma from 4 months earlier and non-compacted LV presented with dyspnea, severe LV systolic dysfunction, and multiple large LV clots.
Discussion: Non-compacted LV can be a risk factor to exacerbate the cardiotoxicity of cancer therapeutics and lead to severe LV systolic failure. Additionally, severe LV systolic dysfunction, advanced stages of the lung cancer, the hypercoagulable state of cancer, and chemotherapy drugs like platinum agents could result in the formation of multiple large clots in the LV. (Iranian Heart Journal 2023; 24(2): 94-99)

Keywords

References

  1. Hirano M, Kimura K, Ishigaki T, et al. High Prevalence of Left Ventricular Non-Compaction and Its Effect on Chemotherapy-Related Cardiac Dysfunction in Patients with Hematological Diseases. Circulation Journal 2020. doi:10.1253/circj. CJ-20-0344.
  2. Di Nisio M, Carella C, Natoli C, et al. Rivaroxaban for Cancer-associated Cardiac Thrombosis. The American Journal of Medicine. 2015; 128(10): e43-4. http://dx.doi.org/10.1016/j.amjmed.2015.05.031.
  3. Aronsona D, Brennerb B. Arterial thrombosis and cancer. Thrombosis Research. 2018; 164: 23–28. https://doi.org/10.1016/j.thromres.2018.01.003.
  4. Zuccarino F, Vollmer I, Sanchez G, et al. Left Ventricular Noncompaction: Imaging findings and Diagnostic Criteria. AJR. 2015; 204:519–530. DOI:10.2214/AJR.13.12326.
  5. Moradia S, Ghelich Oghlia M, Alizadehasl A, et al. MFP-Unet: A novel deep learning based approach for left ventricle segmentation in echocardiography. Physica Medica. 2019; 67: 58–69. https://doi.org/10.1016/j.ejmp.2019.10.001.
  6. Sadeghpoor A, Alizadeasl A. The Right Ventricle: A Comprehensive Review From Anatomy, Physiology, and Mechanics to Hemodynamic, Functional, and Imaging Evaluation. Arch Cardiovasc Imaging. 2016; doi: 10.5812/acvi.35717.
  7. Ikeda A, Tamachik A E, Mizutani M, et al. Rapid occurrence of left ventricular thrombus associated with platinum‑based chemotherapy plus cetuximab for the treatment of metastatic squamous cell carcinoma of the head and neck: A case report. MOLECULAR AND CLINICAL ONCOLOGY. 2017; 7: 833-836. DOI:10.3892/mco.2017.1393.
  8. Sheth RA, Niekamp A, Quencer KB, et al. Thrombosis in cancer patients: etiology, incidence, and management. Cardiovascular Diagnosis and Therapy. 2017; 7: 178-85. http://dx.doi.org/10.21037/cdt.2017.11.02.
  9. McBane RD. Arterial Thrombosis and Cancer: Implications for Screening and Risk Modification. Mayo Clin Proc. 2021; 96(3):526-8. https://doi.org/10.1016/j.mayocp.2021.01.013.
Iranian Heart Journal
Volume 24, Issue 2
April 2023
Pages 94-99

Files

Share

How to cite

Statistics